NOD1 antagonist-2
NOD1 antagonist-2 (compound 66) is an orally active selective antagonist of both human and mouse NOD1. NOD1 antagonist-2 (compound 66) antagonizes NOD1-induced NF-κB and MAPK pathways[1].
Product Specifications
UNSPSC
12352005
Target
NOD-like Receptor (NLR)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CS(C1=CC=C(N=C(Cl)N(C2=CC(NS(=O)(C3=C(F)C=CC=C3F)=O)=C(Cl)C=C2)C4=O)C4=C1)(=O)=O
Molecular Formula
C21H13Cl2F2N3O5S2
Molecular Weight
560.38
References & Citations
[1]Xinhua Liu, et al. Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection. J Med Chem. 2024 Dec 26;67 (24) :22145-22167.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NOD1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC404139 20 µg
Endothelin 3 (EDN3) (NM_207034) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC741631-100 1x 100 µL
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/1631), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details